Immunomedics

Developer of antibodies and antibody-drug conjugates for the treatment of cancer and autoimmune diseases

placeMorris Plains, New Jersey, United States calendar_todayFounded 1982 groups358 employees language immunomedics.com

Registered entities

Investor mix

8 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital450%
Private equity225%
Other / undisclosed225%
Coming soon